You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 107 No. 2, Feb 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (42)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Demethylchlortetracycline and Tetracycline

A Critical Comparison: In Vitro Activity, Serum Concentrations, and Effect of Serum Binding

C. EVANS ROBERTS, JR., M.D.; DAVID M. PERRY, M.D.; HENRY A. KUHARIC, M.D.; WILLIAM M. M. KIRBY, M.D.

Arch Intern Med. 1961;107(2):204-211.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In September, 1959, a new tetracycline compound, demethylchlortetracycline* (here-after referred to as DMCT), became available for general use. This compound is reported to be identical in structure to chlortetracycline except for the absence of a methyl group in the 6-position.1 In early studies it was found to be more resistant to acid and alkali degradation than the other tetracyclines in common use,1 and to be generally more active against bacterial pathogens than tetracycline (hereafter referred to as TC) or oxytetracycline.2-5 The amount of DMCT absorbed from the gastrointestinal tract of man following a single dose was less than with TC,6,11 but Kunin and Finland found that the serum half-life was 44% greater for DMCT than for TC, and the renal clearance of the former drug was only 43% of the latter.7 Assays of serum antibacterial activity after equal doses of the 2 drugs showed significantly . . . [Full Text PDF of this Article]


Author Affiliations

SEATTLE

From the Department of Medicine, University of Washington School of Medicine and the King County Hospital, Seattle.


Footnotes

Submitted for publication April 8, 1960.

This work was supported in part by a grant from Lederle Laboratories Division, American Cyanamid Company.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.